F. Piccinelli et al. / Tetrahedron: Asymmetry 14 (2003) 393–398
397
1H, J=4.8, 15); 1.5 (d, 3H, J=7); 1.68 (s, 3H); 1.78 (d,
3H, J=7); 2.26 (dd, 1H, J=3.4, 15); 2.48 (m, 2H); 3.85
(dd, 1H, J=3.4, 4.8); 4.60 (s, 1H); 4.8 (s, 1H); 4.9–5.3
(broad, 1H); 5.91 (q, 1H, J=7); 7.18–7.43 (m, 10ArH).
13C NMR l: 16.0, 18.0, 22.7, 29.5, 35.5, 46.0, 51.0,
52.6, 54.6, 63.2, 118.2, 125.8, 126.5, 127.9, 128.3, 138.3,
139.5, 141.4, 169.4, 169.6. [h]D −89.7 (c 1.46, CHCl3).
Anal. calcd for C25H28N2O2: C, 77.29; H, 7.26; N, 7.21.
Found: C, 77.55; H, 7.28; N, 7.23%.
J=6.9); 5.95–6.1 (m, 1H); 7.2–7.5 (m, 10ArH). 13C
NMR l: 16.2, 19.4, 37, 39.9, 44.1, 50.7, 53.3 (broad),
54.4, 65.5, 117.9, 118.1, 126.1, 126.7, 127.3, 127.7,
128.3, 133.8, 138.7, 139.4, 141.6, 168.6, 170.1. [h]D
+50.9 (c 2.52, CHCl3). Anal. calcd for C27H30N2O2: C,
78.23; H, 7.29; N, 6.76. Found: C, 78.5; H, 7.32; N,
6.75%.
3.5.6. (3R,6S,1%S)-1, 4-Bis-(1%-phenethyl)-2,5-dioxo-8-
methylene-3-methoxymethyl-1,4-diazabicy-
clo[3.2.2]nonane, 7d. The product was obtained, as an
oil, in 86% yield by alkylating 3 with methoxymethyl-
3.5.2.
(3S,6R,1%S)-1,4-Bis-(1%-phenethyl)-3-allyl-2,5-
dioxo-8-methylene-1,4-diazabicyclo[3.2.2]nonane, 6c. The
product was obtained, as an oil, in 70% yield by
alkylating 2 with allylbromide. 1H NMR l: 1.54 (d, 3H,
J=7); 1.79 (d, 3H, J=6.8); 2.25 (dd, 1H, J=3.2, 15);
2.58 (m, 3H); 2.95 (dd, 1H, J=7, 15.4); 3.11 (dd, 1H,
J=6, 15.8); 3.82 (dd, 1H, J=3.6, 4.4); 4.61 (s, 1H); 4.88
(s, 1H); 5 (m, 1H); 5.15 (m, 1H); 5.6 (m, 1H); 5.98 (q,
1H, J=7); 6.0 (m, 1H); 7.3 (m, 10ArH).13C NMR l:
16.1, 17.5, 35.7, 40.2, 44.8, 50.9, 52.9, 54.4, 65.2, 118.5,
119, 125.4, 126.1, 127.5, 127.7, 127.9, 128.3, 133.1,
138.3, 139.2, 141.6, 168.7, 169.9. [h]D −117.1 (c 1.1,
CHCl3). Anal. calcd for C27H30N2O2: C, 78.23; H, 7.29;
N, 6.76. Found: C, 78.45; H, 7.3; N, 6.78%.
1
bromide. H NMR l: 1.57 (d, 3H, J=6.8); 1.83 (d, 3H,
J=6.8); 2.3–2.7 (m, 4H); 3.48 (s, 3H); 3.70 (dd, 1H,
J=4, 4.6); 3.98 (broad, 2H); 4.84 (s, 2H); 5.10 (broad,
1H); 5.85 (q, 1H, J=6.8); 7.2–7.6 (m, 10ArH). 13C
NMR l: 16.6, 18.5, 37.1, 41.1, 51.0, 55.3 (broad), 59.0,
66.3, 72.9, 118.4, 126.6, 126.7, 127.7, 127.8, 128.6,
139.0, 139.6, 141.7, 168.3, 169.6. [h]D +20.8 (c=0.83,
CHCl3). Anal. calcd for C26H30N2O3: C, 74.61; H, 7.23;
N, 6.69. Found: C, 74.5; H, 7.22; N, 6.66%.
3.6. Conversion of 6b–d and 7b–d into 4b–d and 5b-d,
respectively
The procedure followed was that previously described
to prepare 4a and 5a from 2 and 3, respectively. The
reaction products, recovered in practically quantitative
yield, were submitted to silica gel chromatography elut-
ing with hexane/ethyl acetate. However, the enan-
tiomers 4b–d and 5b–d were not obtained in sufficiently
pure form for elemental analysis and to measure the
specific rotation because of the presence of LiCl traces.
3.5.3.
(3S,6R,1%S)-1,4-Bis-(1%-phenethyl)-2,5-dioxo-8-
methylene-3-methoxymethyl-1,4-diazabicy-
clo[3.2.2]nonane, 6d. The product was obtained as an oil
in 70% yield by alkylating 2 with methoxymethylbro-
mide. 1H NMR l: 1.4–1.55 (m, 1H), 1.49 (d, 3H, J=7);
1.8 (d, 3H, J=7); 2.23 (dd, 1H, J=3, 14.6); 2.6 (qAB
,
2H, J=15); 3.40 (s, 3H); 3.75 (dd, 1H, J=3, 5.1);
3.9–4.18 (broad, 2H); 4.57 (s, 1H); 4.9 (m, 2H); 5.9 (q,
1H, J=7); 7.18–7.5 (m, 10ArH). 13C NMR l: 16.2,
17.2, 35.8, 41, 50.8, 54.1, 54.7, 59.1, 65.8, 73.3, 118.7,
125.7, 126.3, 127.9, 128.1, 128.4, 138.4, 139.0, 142.4,
168.0, 169.4. [h]D −95.4 (c 0.75, CHCl3). Anal. calcd for
C26H30N2O3: C, 74.61; H, 7.23; N, 6.69. Found: C,
74.55; H, 7.2; N, 6.7%.
3.6.1. (3R,6R)-2,5-Dioxo-3-methyl-8-methylene-1,4-diaz-
abicyclo[3.2.2]nonane, 4b. The product was obtained as
1
a wax in 92% yield. H NMR (CD3OD) l: 1.38 (s, 3H);
2.4–2.7 (m, 4H); 3.82 (dd, 1H, J=3.2, 4.4); 4.96 (m,
2H). 13C NMR (CD3OD) l: 20.5, 36.0, 44.7, 53.7, 57.0,
117.4, 139.9, 168.4, 169.5. [h]D −86.0 (c 0.4, CH3OH).
Anal. calcd for C9H12N2O2: C, 59.99; H, 6.71; N, 15.55.
Found: C, 60.2; H, 6.7; N, 15.5%.
3.5.4. (3S,6S,1%S)-1, 4-Bis-(1%-phenethyl)-2,5-dioxo-3-
methyl-8-methylene-1,4-diazabicyclo[3.2.2]nonane,
7b.
The product was obtained, as an oil, in 90% yield by
3.6.2.
(3S,6R)-2,5-Dioxo-3-allyl-8-methylene-1,4-diaz-
1
alkylating 3 with iodomethane. H NMR l: 1.35 (s,
abicyclo[3.2.2]nonane, 4c. The product was obtained as
1
3H); 1.56 (d, 3H, J=7.2); 1.71 (d, 3H, J=7.2); 2.45
(dd, 1H, J=3.6, 14.7); 2.51 (s, 2H); 2.73 (dd, 1H,
J=3.6, 14.7); 3.92 (t, 1H, J=3.6); 4.86 (s, 1H); 4.91 (s,
1H); 5.7–6 (broad, 1H); 5.86 (q, 1H, J=7.2); 7.1–7.4
(m, 10ArH). 13C NMR l: 16.6, 17.8, 22.6, 37.6, 46.8,
51.0 (broad), 54.6, 63.1, 118.5, 126.3, 126.6, 126.8,
127.9, 128.3, 128.7, 139.7, 139.8, 142.0, 170.0, 170.2.
[h]D −76.6 (c 1.15, CHCl3). Anal. calcd for C25H28N2O2:
C, 77.29; H, 7.26; N, 7.21. Found: C, 77.5; H, 7.28; N,
7.2%.
a wax in 85% yield. H NMR (CD3OD) l: 2.3–2.8 (m,
6H); 3.81 (dd, 1H, J=3.4, 4.8); 4.97 (s, 2H); 5.1–5.3 (m,
2H); 5.7–6 (m, 1H). 13C NMR (CD3OD) l: 38, 40.4,
45.5, 55.3, 61, 119.3, 120.1, 133.4, 141.6, 174.2. [h]D
−117.2 (c 0.48, CH3OH). Anal. calcd for C11H14N2O2:
C, 64.06; H, 6.84; N, 13.58. Found: C, 63.92; H, 6.87;
N, 13.55%.
3.6.3. (3S,6R)-2,5-Dioxo-8-methylene-3-methoxymethyl-
1,4-diazabicyclo[3.2.2]nonane, 4d. The product was
1
obtained as a wax in 90% yield. H NMR (CD3 OD) l:
3.5.5.
(3R,6S,1%S)-1,4-Bis-(1%-phenethyl)-3-allyl-2,5-
2.52 (qAB, 2H, J=14.6); 2.53–2.73 (m, 2H); 3.42 (s,
3H); 3.52 (d, 1H, J=9.6); 3.72 (d, 1H, J=9.6); 3.85
(dd, 1H, J=3.6, 4.8); 5 (m, 2H). 13C NMR (CD3OD) l:
38.1, 41.7, 55.3, 59.6, 61.3, 73.8, 119.5, 141.2, 173.5,
173.8. [h]D −77.4 (c 0.42, CH3OH). Anal. calcd for
C10H14N2O3: C, 57.13; H, 6.71; N, 13.33. Found: C,
57.1; H, 6.73; N, 13.35%.
dioxo-8-methylene-1,4-diazabicyclo[3.2.2]nonane, 7c. The
product was obtained, as an oil, in 76% yield by
alkylating 3 with allylbromide. 1H NMR l: 1.59 (d, 3H,
J=7.4); 1.79 (d, 3H, J=6.9); 2.43 (m, 3H); 2.55–2.85
(m, 2H); 2.95–3.2 (broad, 1H); 3.80 (t, 1H, J=3.9); 4.65
(s, 1H); 4.80 (s, 1H); 5.1–5.35 (m, 3H); 5.9 (q, 1H,